NASDAQ:RGEN (Repligen Corporation)

About rgen

A biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system.

Repligen Corporation (NASDAQ: RGEN) Latest News

No posts found.